HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$1.00
Day range
$0.94 - $1.01
Year range
$0.62 - $2.50
Market cap
22.43M USD
Avg Volume
302.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.98M | -63.26% |
Net income | -5.00M | 59.18% |
Net profit margin | — | — |
Earnings per share | -0.23 | 70.13% |
EBITDA | -3.97M | 61.79% |
Effective tax rate | -0.62% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.72M | -73.81% |
Total assets | 14.17M | -72.22% |
Total liabilities | 25.09M | -42.84% |
Total equity | -10.91M | — |
Shares outstanding | 22.71M | — |
Price to book | -1.52 | — |
Return on assets | -58.82% | — |
Return on capital | -79.17% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.00M | 59.18% |
Cash from operations | -6.76M | 11.44% |
Cash from investing | 4.20M | -3.45% |
Cash from financing | 167.00K | -16.50% |
Net change in cash | -2.41M | 22.09% |
Free cash flow | -5.09M | -53.19% |
About
Founded
2015
Website
Employees
14